other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}

Adviser Profile

As of Date 03/31/2024
Adviser Type - Large advisory firm
Number of Employees 26 -13.33%
of those in investment advisory functions 16 -27.27%
Registration SEC, Approved, 7/27/2018
Other registrations (2)
AUM* 1,622,845,390 18.80%
of that, discretionary 1,622,845,390 18.80%
Private Fund GAV* 1,622,845,390 12.20%
Avg Account Size 540,948,463 18.80%
SMA’s No
Private Funds 3
Contact Info 650 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
1B 1B 976M 781M 585M 390M 195M
2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeVenture Capital Fund Count3 GAV$1,622,845,390

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser ARTHUR VENTURES Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.5b Other Fund- Total Private Fund GAV3.0b AUM1.5b #Funds13
Adviser CLARUS VENTURES, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.1b Other Fund- Total Private Fund GAV2.2b AUM1.1b #Funds9
Adviser CROSS CREEK ADVISORS, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.3b Other Fund- Total Private Fund GAV2.7b AUM1.3b #Funds17
Adviser HAUN VENTURES MANAGEMENT LP Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.5b Other Fund- Total Private Fund GAV3.0b AUM1.5b #Funds2
Adviser EDISON PARTNERS MANAGEMENT, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.7b Other Fund- Total Private Fund GAV3.4b AUM1.7b #Funds15
Adviser RADIAN CAPITAL LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.1b Other Fund- Total Private Fund GAV2.2b AUM1.1b #Funds6
Adviser SV HEALTH INVESTORS, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund961.9m Other Fund- Total Private Fund GAV1.9b AUM1.1b #Funds13
Adviser GGP MANAGEMENT, L.P. Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund896.9m Other Fund- Total Private Fund GAV1.8b AUM1.2b #Funds11
Adviser ENERGIZE CAPITAL LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.4b Other Fund- Total Private Fund GAV2.8b AUM1.4b #Funds20
Adviser QUONA CAPITAL MANAGEMENT LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.1b Other Fund- Total Private Fund GAV2.2b AUM1.1b #Funds8

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker14179K101 Stock NameCARGO THERAPEUTICS INC $ Position$72,505,613 % Position15.00% $ Change-21.00% # Change7.00%
Stck Ticker603170101 Stock NameMINERALYS THERAPEUTICS INC $ Position$59,376,517 % Position12.00% $ Change-9.00% # Change0.00%
Stck Ticker80706P103 Stock NameSCHOLAR ROCK HLDG CORP $ Position$56,549,113 % Position12.00% $ Change-53.00% # Change0.00%
Stck Ticker64135M105 Stock NameNEUROGENE INC $ Position$46,134,878 % Position10.00% $ Change-29.00% # Change0.00%
Stck Ticker65487U108 Stock NameNKARTA INC $ Position$22,269,087 % Position5.00% $ Change-45.00% # Change0.00%
Stck Ticker03940C100 Stock NameARCELLX INC $ Position$25,036,447 % Position5.00% $ Change-21.00% # Change0.00%
Stck Ticker28658R106 Stock NameELIEM THERAPEUTICS INC $ Position$23,188,504 % Position5.00% $ Change # Change
Stck Ticker52635N103 Stock NameLENZ THERAPEUTICS INC $ Position$20,894,498 % Position4.00% $ Change-23.00% # Change0.00%
Stck TickerG29687103 Stock NameAVADEL PHARMACEUTICALS PLC $ Position$13,603,430 % Position3.00% $ Change # Change
Stck Ticker21217B100 Stock NameCONTINEUM THERAPEUTICS INC $ Position$10,369,067 % Position2.00% $ Change # Change

Brochure Summary

Overview

ADVISORY BUSINESS A. Description of the Advisory Firm Samsara is a Delaware limited liability company that commenced operations in 2016 and has a principal place of business in Palo Alto, CA. Samsara’s founder and managing member is Srinivas “Srini” Akkaraju, MD, PhD. B. Types of Advisory Services Samsara provides discretionary investment advisory services to Samsara BioCapital, L.P., a private investment vehicle organized as a Delaware limited partnership (“Samsara LP), SMSR B1, L.P., a private investment vehicle formed in the Cayman Islands that serves as a feeder fund to Samsara LP (“SMSR B1”) and 565 SPV I, L.P., a private investment vehicle organized as a Delaware limited partnership (“565 SPV I” and together with Samsara LP and SMSR B1, the “Funds”). An affiliate of Samsara, Samsara BioCapital GP, LLC (“Samsara GP”) serves as the general partner of Samsara LP. An affiliate of Samsara, 565 SPV GP I, LLC (“SPV GP I”) serves as the general partner of 565 SPV I, and SMSR B1 GP, LLC serves as the general partner of SMSR B1 (“SMSR B1 GP”) and together with Samsara GP and SPV GP I, the “GP Entities”). Samsara GP, SMSR B1 GP and SPV GP I are related persons of Samsara. Samsara is a venture capital firm which primarily provides investment advice on and manages investments in public and private securities and related assets and revenue streams of life sciences and health care companies (“Portfolio Companies”). These securities include but are not limited to: (1) equity securities; (2) warrants; (3) corporate debt securities, including convertible bonds; (4) options; (5) money market funds; and (6) private “non-public” investment opportunities. The activities of the Funds are governed by their limited partnership agreements, which specifies the investment guidelines and investment restrictions applicable to the Fund, and other offering documents (collectively, the “Governing Documents”) provided to the investors in the Funds (the “Investors”). Samsara manages the Funds’ investments pursuant to the Governing Document. The GP Entities retain management authority over the business and affairs of the Funds, but delegate their investment discretion to Samsara. Samsara offers investment advice solely with respect to the investments made by the Funds. Such services consist of investigating, identifying, and evaluating investment opportunities, structuring, negotiating, and making investments on behalf of the Funds, managing
and monitoring the performance of such investments, and disposing of such investments. In the future, Samsara may establish co-investment vehicles and may offer investments in the co- investment vehicles to certain Investors of Samsara LP at the discretion of Samsara GP. There is no guarantee for any Investor in the Fund that it will be offered such co-investment opportunities. All decisions regarding whether and to whom to offer co-investment opportunities are made in the sole discretion of Samsara and/or Samsara GP subject to any restrictions contained in the Governing Documents of the Funds. C. Client Investment Objectives and Restrictions Samsara generally has broad and flexible investment authority with respect to the Funds. The Funds’ investment objectives and strategies are set forth in the Funds’ Governing Documents. All Investors are provided with limited partnership agreement and other offering documents prior to making an investment. Investors are urged to carefully review those documents prior to making an investment in a Fund. Samsara tailors its investment advice to the Funds in accordance with the Funds’ investment objectives, guidelines, restrictions and strategy as set forth in the Governing Documents. Samsara does not tailor its advisory services to the individual needs of Investors. Since Samsara does not provide individualized advice to Investors, Investors must consider whether a particular Fund meets their investment objectives and risk tolerance prior to investing. Samsara and the GP Entities have entered into side letter agreements with certain Investors. Side letters are negotiated prior to investment and may establish rights that supplement or alter the terms of the Governing Documents. Pursuant to such side letters, Samsara, or the GP Entities, have granted rights to certain Investors which are generally not available to other Investors (including without limitation, advisory committee representation, certain transparency rights, reporting rights, and confidentiality). Once invested in a Fund, Investors generally cannot impose additional investment guidelines, restrictions or other requirements on the Fund. D. Wrap Fee Programs Samsara does not participate in wrap fee programs. E. Assets Under Management As of December 31, 2023, Samsara had $1,622,845,390 in regulatory assets under management on a discretionary basis. Samsara does not currently manage any client assets on a non-discretionary basis.